Stocks and InvestingStocks and Investing
Mon, July 18, 2022
Sat, July 16, 2022
Fri, July 15, 2022

Matthew Harrison Maintained (AMGN) at Hold with Increased Target to $253 on, Jul 15th, 2022


Published on 2024-10-27 21:57:31 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Amgen Inc." (AMGN) at Hold with Increased Target from $239 to $253 on, Jul 15th, 2022.

Matthew has made no other calls on AMGN in the last 4 months.



There are 7 other peers that have a rating on AMGN. Out of the 7 peers that are also analyzing AMGN, 5 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Risinger of "SVB Leerink" Initiated at Hold and Held Target at $256 on, Monday, May 23rd, 2022
  • Salim Syed of "Mizuho" Maintained at Hold with Increased Target to $208 on, Tuesday, May 10th, 2022
  • Evan Seigerman of "BMO Capital" Maintained at Hold with Decreased Target to $243 on, Thursday, April 28th, 2022
  • Gregory Renza of "RBC Capital" Maintained at Hold with Increased Target to $223 on, Thursday, April 28th, 2022
  • Carter Gould of "Barclays" Maintained at Hold with Increased Target to $236 on, Tuesday, April 12th, 2022


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $290 on, Wednesday, June 1st, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $260 on, Thursday, April 28th, 2022